Fibroblast Growth Factor 23 in Multiple Myeloma Patients with Renal Impairment

被引：0
|
作者：
Ibrahim, Nahed Moawad [1 ]
El Afifi, Amal Mostafa [1 ]
Abdelallim, Nada Shawky Rizk [1 ]
Abdullah, Nour El Hoda Hussein [1 ]
机构：
[1] Ain Shams Univ, Clin Hematol & Bone Marrow Transplantat Unit, Fac Med, Cairo, Egypt
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2021年 / 21卷
关键词：
MM; fibroblast growth factor 23; newly diagnosed multiple myeloma; renal impairment;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MM-299
引用
收藏
页码：S434 / S434
页数：1
相关论文
共 50 条
  • [21] Treatment with lenalidomide and dexamethasone in patients with multiple myeloma and renal impairment
    Dimopoulos, Meletios A.
    Terpos, Evangelos
    Goldschmidt, Hartmut
    Alegre, Adrian
    Mark, Tomer
    Niesvizky, Ruben
    CANCER TREATMENT REVIEWS, 2012, 38 (08) : 1012 - 1019
  • [22] RENAL IMPAIRMENT IN PATIENTS WITH MULTIPLE MYELOMA : A SINGLE CENTER EXPERIENCE
    El Meknassi, Imen
    Guedri, Yosra
    Azzabi, Awatef
    Mrabet, Sanda
    Fradi, Asma
    Sahtout, Wissal
    Ben Aicha, Narjes
    Zellama, Dorsaf
    Achour, Abdellatif
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34
  • [23] Carfilzomib in multiple myeloma patients with renal impairment: pharmacokinetics and safety
    Badros, A. Z.
    Vij, R.
    Martin, T.
    Zonder, J. A.
    Kunkel, L.
    Wang, Z.
    Lee, S.
    Wong, A. F.
    Niesvizky, R.
    LEUKEMIA, 2013, 27 (08) : 1707 - 1714
  • [24] MULTIPLE MYELOMA AND RENAL IMPAIRMENT. A SERIES OF 162 PATIENTS
    Azaiez, Seif
    Barbouch, Samia
    Harzallah, Amal
    Jaziri, Fatima
    Aoudia, Raja
    Gorsane, Imen
    Ben Hamida, Fethi
    Ben Abdelghani, Khaoula
    Ben Abdallah, Taieb
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 375 - 376
  • [25] TRANSGELIN AS A POTENTIAL MARKER OF RENAL IMPAIRMENT IN MULTIPLE MYELOMA PATIENTS
    Woziwodzka, Karolina
    Malyszko, Jolanta
    Banaszkiewicz, Malgorzata
    Orawska, Ewa Koc-Z
    Dumnicka, Paulina
    Jurczyszyn, Artur
    Batko, Krzysztof
    Maleszka, Aleksandra
    Krzanowski, Marcin
    Miarka, P.
    Zorawski, Marcin
    Malyszko, Jacek
    Drozdz, Ryszard
    Kuznieswki, Marek Jan
    Krzanowska, Katarzyna
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 1035 - 1035
  • [26] Carfilzomib in multiple myeloma patients with renal impairment: pharmacokinetics and safety
    A Z Badros
    R Vij
    T Martin
    J A Zonder
    L Kunkel
    Z Wang
    S Lee
    A F Wong
    R Niesvizky
    Leukemia, 2013, 27 : 1707 - 1714
  • [27] FIBROBLAST GROWTH FACTOR-23 LEVELS IN CHRONIC RENAL FAILURE PATIENTS ON DIFFERENT DIALYSIS TREATMENTS AND IN PATIENTS WITH RENAL TRANSPLANTATION
    Ozdem, S.
    Ersoy, F.
    Yilmaz, V. T.
    Donmez, L.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S567 - S567
  • [28] MULTIPLE-MYELOMA AND RENAL IMPAIRMENT
    FINE, J
    LUKE, RG
    REES, ED
    LANCET, 1973, 2 (7839): : 1205 - 1206
  • [29] The fibroblast growth factors in multiple myeloma
    Krejci, P
    Mekikian, PB
    Wilcox, WR
    LEUKEMIA, 2006, 20 (06) : 1165 - 1168
  • [30] The fibroblast growth factors in multiple myeloma
    P Krejci
    P B Mekikian
    W R Wilcox
    Leukemia, 2006, 20 : 1165 - 1168
12345